SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-011579
Filing Date
2019-10-09
Accepted
2019-10-09 16:43:55
Documents
4
Period of Report
2019-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT biei_8k.htm 8-K 32751
2 EQUITY PURCHASE AGREEMENT biei_ex101.htm EX-10.1 256135
3 REGISTRATION RIGHTS AGREEMENT biei_ex102.htm EX-10.2 119986
4 CONVERTIBLE PROMISSORY NOTE biei_ex103.htm EX-10.3 181501
  Complete submission text file 0001654954-19-011579.txt   591532
Mailing Address P.O. BOX 25 JACKSON CENTER PA 16133
Business Address P.O. BOX 25 JACKSON CENTER PA 16133 724-633-7033
PREMIER BIOMEDICAL INC (Filer) CIK: 0001515740 (see all company filings)

IRS No.: 272635666 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54563 | Film No.: 191144772
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences